dr. pennell on the evolution of targeted treatment in nsclc
Published 3 years ago • 163 plays • Length 2:12Download video MP4
Download video MP3
Similar videos
-
2:22
dr. pennell on the evolution of targeting her2 in lung cancer
-
1:18
dr. lopategui on the evolution of targeted therapies in nsclc
-
1:41
dr. pennell on remaining challenges in nsclc
-
1:39
dr. pennell on benefits of liquid biopsies in lung cancer
-
1:34
dr. pennell on the use of brigatinib in alk nsclc
-
4:23
evolution of targeted therapy in advanced nsclc
-
2:10
dr. pennell on unique treatment-related toxicities in lung cancer
-
29:37
dr gengwen tian, nkt trial update & new immunotherapy trial opening
-
2:26
dr. pennell on the underutilization of genetic testing in lung cancer
-
2:10
dr. pennell on importance of egfr testing in nsclc
-
1:18
dr. natale on the evolution of immunotherapy in nsclc
-
2:11
dr. pennell on considerations for immediate treatment in lung cancer
-
1:22
dr. pennell on challenges with ngs in lung cancer
-
4:05
the evolution of alk/ros1-targeted therapy in nsclc
-
1:53
dr. pennell on the risks associated with sequential therapy with immunotherapy/tkis in lung cancer
-
0:36
dr. camidge on the fda approval of pembrolizumab for squamous nsclc
-
1:32
dr. gettinger on the evolution of immunotherapies in lung cancer
-
2:40
dr. gould on the implications of the nelson trial in lung cancer
-
3:30
the cost-effectiveness of targeted therapies in nsclc